biote Corp.

NasdaqGM BTMD

biote Corp. Market Capitalization on January 14, 2025: USD 299.09 M

biote Corp. Market Capitalization is USD 299.09 M on January 14, 2025, a 10.29% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

biote Corp. 52-week high Market Capitalization is USD 491.78 M on July 16, 2024, which is 64.43% above the current Market Capitalization.
biote Corp. 52-week low Market Capitalization is USD 222.95 M on January 31, 2024, which is -25.46% below the current Market Capitalization.
biote Corp. average Market Capitalization for the last 52 weeks is USD 340.76 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NasdaqGM: BTMD

biote Corp.

CEO	Ms. Teresa S. Weber
IPO Date	April 28, 2021
Location	United States
Headquarters	1875 West Walnut Hill Lane
Employees	194
Sector	Health Care
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies

Description

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

Key trends

Past 5 years